GI Partners to take Atlas Technical Consultants private in $1bn deal

GI Partners to take Atlas Technical Consultants private in $1bn deal

GI Partners, a US-based private investment firm, will acquire Atlas Technical Consultants, an infrastructure and environmental solutions provider, in an all-cash transaction valued at around $1.05 billion, plus outstanding debt. Post-closing, Atlas Technical Consultants will become a private company and its shares will cease to trade on Nasdaq. Shareholders of the project delivery management firm […]

Hindustan Zinc becomes first Indian mining company to deploy electric vehicle for underground operations

Hindustan Zinc becomes first Indian mining company to deploy electric vehicle for underground operations

India’s Hindustan Zinc has deployed a battery electric vehicle (BEV) for its underground mining operations at its Sindesar Khurd mine, becoming the industry first to lead the green race in the country. The deployment of Normet Agitator SmartDrive EV forms part of Hindustan Zinc’s strategy to gradually shift to battery-powered service equipment and utility vehicles […]

FDA approves Guardant360 CDx assay as companion diagnostic for Menarini’s ORSERDU for metastatic breast cancer

FDA approves Guardant360 CDx assay as companion diagnostic for Menarini’s ORSERDU for metastatic breast cancer

Guardant Health, an oncology company, has secured the approval of the US Food and Drug Administration (FDA) for the company’s Guardant360 CDx liquid biopsy assay as a companion diagnostic for ORSERDU (elacestrant). The FDA approval as a companion diagnostic for ORSERDU marks Guardant Health’s first in breast cancer and the fifth for the Guardant360 CDx […]

Sanofi, Regeneron get Dupixent EC approval for eosinophilic esophagitis

Sanofi, Regeneron get Dupixent EC approval for eosinophilic esophagitis

French pharmaceutical company Sanofi and Regeneron, an American biotechnology company, have received the approval of the European Commission (EC) to market their Dupixent (dupilumab) injection in the European Union for eosinophilic esophagitis (EoE). Dupixent is indicated in adults and adolescents 12 years and over, who are not candidates for conventional medicinal treatment. With the approval, […]

North Plains Connector project : Allete, Grid United partner to develop $2.5bn transmission line

North Plains Connector project : Allete, Grid United partner to develop $2.5bn transmission line

Clean energy company Allete and Grid United, a transmission company, have joined forces to develop the North Plains Connector project, a core transmission link in the US to increase the reliability of the nation’s electric grid, with approximately $2.5 billion investment. The transmission line will connect three regional US electric energy markets, namely the Midcontinent […]

Cheche Technology to go public through merger with Prime Impact Acquisition I

Cheche Technology to go public through merger with Prime Impact Acquisition I

Chinese auto insurance technology platform Cheche Technology will merge with Prime Impact Acquisition I, a special purpose acquisition company (SPAC), to become a publicly listed company. The proposed merger represents a pre-money equity value of $760 million for Cheche Technology and is anticipated to bring in gross proceeds of around $68 million and additional financing […]

Sol-Gel acquires Gorlin syndrome drug candidate Patidegib from PellePharm

Sol-Gel acquires Gorlin syndrome drug candidate Patidegib from PellePharm

Sol-Gel Technologies, an Israel-based dermatology company, has acquired patidegib, a Gorlin syndrome drug candidate in phase 3 development, from US-based biotechnology company PellePharm, in a deal worth up to $75 million. Patidegib has breakthrough therapy and orphan drug designations from the US Food and Drug Administration (FDA). With potential market of more than $300 million, […]

Lilly gets Jaypirca FDA approval for mantle cell lymphoma

Lilly gets Jaypirca FDA approval for mantle cell lymphoma

Loxo@Lilly, the oncology division of Eli Lilly and Company (Lilly), has secured the accelerated approval of the US Food and Drug Administration (FDA) for Jaypirca (pirtobrutinib) for the treatment of mantle cell lymphoma (MCL). To be available in 100mg and 50mg tablets, Jaypirca is specifically indicated for the treatment of adult patients having relapsed or […]

Darlington New Nuclear Project : Aecon, GE Hitachi, and SNC-Lavalin to develop Canada’s first SMR

Darlington New Nuclear Project : Aecon, GE Hitachi, and SNC-Lavalin to develop Canada’s first SMR

Aecon, GE Hitachi and SNC-Lavalin have partnered to develop North America’s first grid-scale small modular reactor at the Darlington New Nuclear Project for Ontario Power Generation (OPG). Under a six-year agreement, the partnership will deploy a BWRX-300 small modular reactor at Ontario Power Generation’s nuclear power project site in Clarington, Ontario before the end of […]

1 12 13 14 15 16 61